Veradermics

MANE13F as of Jun 30, 2026 · next update ~Nov 14

Limited coverage

Only 2 funds we track own this stock, so quarterly sentiment and aggregates may be sparse.

Who's buying MANE

Top funds were split on Veradermics in Q2 (Apr⁠–⁠Jun)

Buying:

FundsInsiders5Congress

Top funds
1 of 2 bought more, 1 sold some. Largest: Viking Global Investors, $192.0M (1% of its portfolio).
Insiders
5 insiders bought, 4 sales in 12 months.
Congress
No trades disclosed in the last 12 months.

2 funds$289.1M held0.7% avg. weightQ2: 1 bought / 1 sold

13F reports are a snapshot as of Jun 30, 2026; funds may have traded since. Insiders often sell for personal reasons (taxes, diversification, planned sales).

Share price · market data, not from 13F reports

Q2 2026

Insider trades (Form 4)

Last 2 years · 9 filings

Net buying$157.21M

Date	Insider	Type	Shares	Price	Value
Aug 19, 2026	Montanova Capital, LLC Director	Sold	750,000	$107.25	$80.44M
Aug 17, 2026	Timothy August Durso CTO	Sold	43,500	$107.82	$4.69M
Aug 17, 2026	Reid Alexander Waldman CEO	Sold	67,500	$107.86	$7.28M
Aug 12, 2026	John W Childs Director	Sold	100,000	$107.12	$10.71M
Feb 5, 2026	John W Childs Director	Bought	294,117	$17.00	$5.00M
Feb 4, 2026	Suvretta Capital Management, LLC Director & 10% Owner	Bought	282,674	$37.30	$10.54M
Feb 5, 2026	Vlad Coric Director	Bought	117,646	$17.00	$2.00M
Feb 5, 2026	Longitude Capital Partners V, LLC 10% Owner	Bought	1,075,000	$17.00	$18.27M
Feb 5, 2026	Patrick G Enright Director & 10% Owner	Bought	1,075,000	$17.00	$18.27M